This program discusses the origins of Oncolytic Immunotherapy (OI) research, and highlights how Amgen has recognized OI and is investigating ways to harness the potential of OI when treating patients with cancer.
View presentation

In this iPub^® edition of Cancer Insights, UPMC CancerCenter, partner with University of Pittsburgh Cancer Institute, feature three of their prominent physician-scientists, highlighting their most promising work. View publication.
View presentation

Leading oncologist Dr Mark Socinski addresses the efficacy, safety, and importance of first-line treatment of metastatic non-squamous non-small cell lung cancer.
View presentation

Dr Ronald Bukowski and Dr Thomas Hutson present this interactive guide reviewing metastatic renal cell carcinoma.
View presentation

Dr George Cannellos will be joined by other clinicians who will provide a regional perspective on the issues surrounding relative dose intensity and the impact of febrile neutropenia and chemotherapy dose Iitensity on patient outcomes.
View presentation

Dr James Mohler and Dr Philip Kantoff review the pathophysiology and management of prostate cancer, while focusing on castration-resistant prostate cancer.
View presentation

This iResource Center highlights some of the organizations in the United States whose mission is to increase research funding; provide emotional and financial support for patients, their families, and caregivers; and promote public awareness and acceptance of patients with prostate cancer.
View presentation

Best Practices and Innovative Heathcare Reform Models

An interactive supplement that provides a new and unique way to review the best practices and innovative healthcare reform models. This supplement covers a value-based insurance design, integrated deliver systems, and innovative health reform models or pay-for-performance initiatives.

The program offers a unique guide to the medical home as a practice-level intervention and lessons to apply to national comprehensive healthcare reform. Learn more